KMT2A and leukemia: Researchers have identified the core regulatory networks for leukemia types such as T-cell acute lymphoblastic leukemia (T-ALL), chronic lymphocytic leukemia (CLL), and mixed-lineage leukemia-rearranged acute myeloid leukemia (MLL-rearranged AML).